Unraveling the Molecular Mechanisms of ABHD5 Membrane Targeting
Curation statements for this article:-
Curated by eLife
eLife Assessment
This study makes a valuable contribution to our understanding of how the lipase regulator ABHD5 may control lipase activity through interactions with lipid droplets and cellular membranes. By combining multiscale molecular dynamics simulations with experimental approaches, the authors provide novel molecular insights into this membrane-protein interaction and present evidence suggesting that the regulatory mechanism depends on protein conformational changes and local membrane remodeling. While much of the evidence supporting the main conclusions is convincing, several aspects of the analysis, interpretation, and discussion remain incomplete. Overall, this work will be of interest to structural and molecular biologists working on lipid metabolism and membrane biophysics.
This article has been Reviewed by the following groups
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
- Evaluated articles (eLife)
Abstract
ABHD5 is a master regulator of PNPLA family lipases, particularly PNPLA2 (ATGL), the rate-limiting triglyceride (TAG) hydrolase in metabolic tissues. Despite its central role in lipid metabolism, the molecular basis by which ABHD5 recognizes membranes and regulates enzymatic activity remains poorly understood. Here, we report an integrated computational-experimental study revealing how the α/β-hydrolase domain-containing protein 5 (ABHD5) dynamically engages lipid droplet (LD) and endoplasmic reticulum membranes to control lipolytic activation. Using multiscale molecular dynamics simulations, hydrogen-deuterium exchange mass spectrometry, and site-directed mutagenesis, we uncover a sequential dual-site membrane recognition mechanism, where the N-terminus provides initial anchoring and a lid helix within the insertion segment forms a crucial secondary contact. Membrane binding triggers a dramatic conformational switch in this lid, expanding the pseudosubstrate pocket and transforming ABHD5 into an active and membrane-localized regulator. This structural transition is coupled to membrane remodeling, inducing localized curvature and forming a triacylglycerol-enriched nanodomain beneath the ABHD5 pseudosubstrate pocket. This bidirectional interaction between ABHD5 and the membrane provides a persuasive mechanism for interfacial activation. Our findings establish new principles for how LD-binding proteins achieve functional specificity through membrane-dependent regulation, offering novel molecular targets for interventions in metabolic diseases.
Article activity feed
-
eLife Assessment
This study makes a valuable contribution to our understanding of how the lipase regulator ABHD5 may control lipase activity through interactions with lipid droplets and cellular membranes. By combining multiscale molecular dynamics simulations with experimental approaches, the authors provide novel molecular insights into this membrane-protein interaction and present evidence suggesting that the regulatory mechanism depends on protein conformational changes and local membrane remodeling. While much of the evidence supporting the main conclusions is convincing, several aspects of the analysis, interpretation, and discussion remain incomplete. Overall, this work will be of interest to structural and molecular biologists working on lipid metabolism and membrane biophysics.
-
Reviewer #1 (Public review):
Summary:
In this study, the authors investigated the detailed structural mechanism of activation of ABHD5 upon interaction with lipid structures (bilayer and LD). The authors used an elaborate multiscale computational workflow, incorporating coarse-grained, all-atom, and enhanced-sampling molecular dynamics simulations, to propose a structural mechanism for the interaction and activation of ABHD5, as well as its specific interaction with TAG in LD. The authors then corroborated these observations with experimental studies involving hydrogen-deuterium exchange coupled with mass spectrometry of wild-type ABHD5 to assess the structural and conformational changes in ABHD5 upon binding, as well as mutagenesis with cell-based and in vitro assays monitoring membrane association, defining specific interactions that …
Reviewer #1 (Public review):
Summary:
In this study, the authors investigated the detailed structural mechanism of activation of ABHD5 upon interaction with lipid structures (bilayer and LD). The authors used an elaborate multiscale computational workflow, incorporating coarse-grained, all-atom, and enhanced-sampling molecular dynamics simulations, to propose a structural mechanism for the interaction and activation of ABHD5, as well as its specific interaction with TAG in LD. The authors then corroborated these observations with experimental studies involving hydrogen-deuterium exchange coupled with mass spectrometry of wild-type ABHD5 to assess the structural and conformational changes in ABHD5 upon binding, as well as mutagenesis with cell-based and in vitro assays monitoring membrane association, defining specific interactions that infer ABHD5 to localize LD.
Strengths:
The manuscript is well-written, and the data are reported in high-quality figures. The experimental design and data analysis are rigorous and support the conclusion. One major strength is the multiscale computational work that reveals a mechanism for the insertion of ABHD5 into lipid bilayers and LD involving the insertion of the N-term portion and the lid helix motif. The design of the computational workflow was very elaborate, and the undertaking was quite extensive, with multiple strategies to (GC, all-atom MD and GaMD). The authors then elegantly generate a hypothesis from these observations to experimentally corroborate the proposed mechanism. Particularly, the HDX-MS data support the engagement of the two regions upon binding, and the fluorescence microscopy data show the role of specific residues in localization/specificity to LD.
Weaknesses:
The following limitation is noted. Central to this manuscript is the model, as observed computationally, that initial lipid interaction by the N-term insertion is followed by the insertion of lid-helix in the membrane, which undergoes a conformational switch in the process. However, HDX-MS reveals that, in the unbound form, the lid helix region displays a bimodal isotopic envelope, revealing two species, one with low uptake, suggesting a structured species and one with high uptake, suggesting a less structured species. It is unclear from the manuscript whether the authors think the bimodality fits EX1 regime kinetics or not. Regardless, the model of unbound ABHD5 shows a lid-helix region devoid of secondary structure (Figure 5A), which is more consistent with the unprotected species. The authors also mention that previous modeling had pointed to the high flexibility of the insertion domain. Upon binding, the lid-helix region seems to be ordered from computational observations and loses bimodality by HDX-MS with a deuterium uptake consistent with the protected species of the bimodal envelop in the unbound form. The authors fall short of interpreting or even discussing what the bimodality of the lid-helix represents in the unbound form. What does the protected species in the bimodal envelope represent? Is it a transition representing lid-helix formation and unfolding? Does it imply that interaction and insertion into the lipid structures are governed by conformational selection? This issue should be at the very least acknowledged and discussed, or optimally investigated by performing more integrative studies of the HDX-MS data with the extensive computational data at hand, using existing protection factor calculations or HDX-guided ensemble refinement methods.
-
Reviewer #2 (Public review):
Summary:
The manuscript describes a combined computational and experimental approach to investigate the ABHD5 binding to and insertion into membranes.
Strengths:
Mutational experiments support computational findings obtained on ABHD5 membrane insertion with enhanced-sampling atomistic simulations.
Weaknesses:
While the addressed problem is interesting, I have several concerns, which fall into two categories:
(A) I see statements throughout the manuscript, e.g. on PNPLA activation, that are not supported by the results.
(B) The presentation of the computational and experimental results lacks in part clarity and detail.
Comments and questions on (A):
(1) I think the following statements in the abstract, which go beyond ABHD5 membrane binding, are not supported by the presented data:
the addition "to control …
Reviewer #2 (Public review):
Summary:
The manuscript describes a combined computational and experimental approach to investigate the ABHD5 binding to and insertion into membranes.
Strengths:
Mutational experiments support computational findings obtained on ABHD5 membrane insertion with enhanced-sampling atomistic simulations.
Weaknesses:
While the addressed problem is interesting, I have several concerns, which fall into two categories:
(A) I see statements throughout the manuscript, e.g. on PNPLA activation, that are not supported by the results.
(B) The presentation of the computational and experimental results lacks in part clarity and detail.
Comments and questions on (A):
(1) I think the following statements in the abstract, which go beyond ABHD5 membrane binding, are not supported by the presented data:
the addition "to control lipolytic activation" in the 3rd sentence of the abstract.
further below ".... transforming ABHD5 into an active and membrane-localized regulator".
(2) The authors state in the Introduction (page numbers and line numbers are missing to be more specific):
"We hypothesize that binding of ABHD5 alters the nanoscale chemical and biophysical properties of the LD monolayer, which, combined with direct protein-protein interactions, enables PNPLA paralogs to access membrane-restricted substrates. This regulatory mechanism represents a paradigm shift from conventional enzyme-substrate interactions to sophisticated allosteric control systems that operate at membrane interfaces."
This hypothesis and the suggested paradigm shift are not supported by the data. Protein-protein interactions are not considered. What is meant by "sophisticated allosteric control"?
(3) The authors state in the Results section:
"We hypothesize that this TAG nanodomain is critical for ABHD5-activated TAG hydrolysis by PNPLA2." In previous pages, the authors state the location of the nanodomain: "TAG nanodomain under ABHD5".
If the nanodomain is located under ABHD5, how can it be accessible to PNPLA2? To my understanding, ABHD5 then sterically blocks access of PNPLA2 to the TAG nandomain.
(4) Another statement: "Our findings suggest that ABHD5-mediated membrane remodeling regulates lipolysis in part by regulating PNPLA2 access to its TAG substrate."
I don't see how the reported results support this statement (see point 3 above).
Comments and questions on (B):
(1) The authors state that the GaMD simulations started "from varying conformations observed during CGMD".
What is missing is a clear description of the CGMD simulation conformations, and the CG simulations as a whole, prior to the results section on GaMD. The authors use standard secondary and tertiary constraints in the Martini CG simulations. Do the authors observe some (constrained) conformational changes of ABHD5 already in the CG simulations (depending on the strength of the constraints)? Or do the conformational changes occur exclusively in the GaMD simulations? Both are fine, but this needs to be described.
(2) The authors write: "Three replicas of GaMD were performed."
Do these replicas lead to similar, or statistically identical, membrane-bound ABHD5 conformations? Is this information, i.e. a statistical analysis of differences in the replica runs, already included in the manuscript?
(3) The authors state on the hydrogen exchange results:
"HDX-MS provided orthogonal experimental evidence for the dynamics of the lid. In solution, a peptide (residues 200-226) spanning the lid helix displayed a bimodal isotopic distribution (Fig. S4), indicating the coexistence of different conformations. Upon LD binding, this distribution shifted to a single, low-exchange peak, demonstrating stabilization of the membrane-bound conformation with reduced solvent accessibility. These experimental observations corroborate our MD simulations."
I find this far too short to be understandable. Also, there are no computational results of ABHD5 in solution that show a bimodal conformational distribution of the lid helix, which is observed in the hydrogen exchange experiments. Which aspects of the MD simulations are corroborated?
-
-
-
